We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$55.7M
Cap. Flow
-$8.71M
Cap. Flow %
-3.85%
Top 10 Hldgs %
50.08%
Holding
105
New
12
Increased
23
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$2.18M
2
ARGX icon
argenx
ARGX
+$1.58M
3
ALT icon
Altimmune
ALT
+$1.14M
4
AAPL icon
Apple
AAPL
+$1.1M
5
XNCR icon
Xencor
XNCR
+$1.08M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.93M
2
KIN
Kindred Biosciences, Inc.
KIN
+$3.32M
3
ORCL icon
Oracle
ORCL
+$1.99M
4
GLD icon
SPDR Gold Trust
GLD
+$1.67M
5
AMD icon
Advanced Micro Devices
AMD
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 39.04%
2 Miscellaneous 27.83%
3 Technology 12.14%
4 Communication Services 8.72%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$804B
$29M 12.79%
67,500
-76,000
-53% -$33.5M
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.1M 6.24%
379,000
+4,000
+1% +$139K
MU icon
3
Micron Technology
MU
$1.09T
$12.6M 5.56%
177,500
+7,500
+4% +$563K
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.2T
$11.6M 5.12%
87,000
-43,000
-33% -$5.93M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$80.1B
$9.68M 4.27%
16,000
+500
+3% +$310K
ABBV icon
6
AbbVie
ABBV
$463B
$8.39M 3.7%
77,750
+750
+1% +$85.7K
ARGX icon
7
argenx
ARGX
$62B
$7.55M 3.33%
25,000
+5,000
+25% +$1.58M
XNCR icon
8
Xencor
XNCR
$1.81B
$7.51M 3.32%
230,000
+33,000
+17% +$1.08M
SPY icon
9
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$804B
$6.65M 2.94%
+15,500
New +$6.84M
BAC icon
10
Bank of America
BAC
$407B
$6.37M 2.81%
150,000
– –
VZ icon
11
Verizon
VZ
$207B
$5.4M 2.38%
100,000
– –
GDX icon
12
VanEck Gold Miners ETF
GDX
$28.7B
$5.16M 2.28%
175,000
-10,000
-5% -$326K
TPB icon
13
Turning Point Brands
TPB
$1.43B
$4.82M 2.13%
101,000
-21,250
-17% -$1.02M
INCY icon
14
Incyte
INCY
$25.5B
$4.82M 2.13%
70,000
+9,000
+15% +$684K
GM icon
15
General Motors
GM
$75.9B
$4.74M 2.09%
90,000
-10,000
-10% -$531K
C icon
16
Citigroup
C
$224B
$4.56M 2.01%
65,000
– –
PRTA icon
17
Prothena Corp
PRTA
$434M
$4.27M 1.89%
60,000
-1,750
-3% -$109K
AMD icon
18
Advanced Micro Devices
AMD
$869B
$4.12M 1.82%
40,000
-15,000
-27% -$1.53M
GLD icon
19
SPDR Gold Trust
GLD
$147B
$3.69M 1.63%
22,500
-10,000
-31% -$1.67M
ORCL icon
20
Oracle
ORCL
$449B
$3.48M 1.54%
40,000
-22,500
-36% -$1.99M
IAU icon
21
iShares Gold Trust
IAU
$64.7B
$3.34M 1.47%
100,000
– –
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$32.8B
$3.3M 1.46%
17,500
– –
PFE icon
23
Pfizer
PFE
$157B
$2.8M 1.23%
65,000
– –
ALT icon
24
Altimmune
ALT
$640M
$2.71M 1.19%
239,200
+93,450
+64% +$1.14M
GLD icon
25
CALL
SPDR Gold Trust
GLD
$147B
$2.63M 1.16%
16,000
+6,000
+60% +$1M
1
2 3 4 5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, DCF Advisers held 105 positions worth $227M, down 20% from $282M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $8.71M in Q3 2021, closing 24 positions and reducing 19 holdings. Its most notable exit was Kindred Biosciences, Inc., an estimated $3.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, DCF Advisers opened a new position in Impel Pharmaceuticals Inc. Common Stock worth $1.83M.

  • DCF Advisers's largest Q3 2021 buy was Impel Pharmaceuticals Inc. Common Stock: 150,000 shares worth $1.83M.
  • DCF Advisers added most to argenx in Q3 2021, an estimated $1.58M increase.
  • DCF Advisers's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $5.93M.
  • DCF Advisers fully exited Kindred Biosciences, Inc. in Q3 2021, selling an estimated $3.32M.
  • DCF Advisers's ten largest holdings make up 50% of its $227M portfolio in Q3 2021.
  • DCF Advisers opened 12 new positions and closed 24 in Q3 2021.
  • DCF Advisers's portfolio value fell 20% quarter-over-quarter to $227M.

Based on DCF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.